scorecardresearch
Tuesday, July 22, 2025
TopicDrug Controller General of India

Topic: Drug Controller General of India

India could ‘withdraw’ curbs on drug exports as pharma firms fear loss of business

In a meeting with govt officials, drug-makers flagged concerns that their clients may start buying products from other countries if restrictions on Indian products continued.

Pantop, Lanzol & other top-selling antacids must carry warning about ‘acute kidney injury’

Studies have shown that PPI-based antacids can injure kidneys and reduce their capacity to filter blood effectively.

Govt approves Rs 30 lakh to Rs 1.20 crore compensation for faulty J&J hip implants

Compensation for the faulty J&J hip implants will be the first ever highest paid relief to disabled patients in India, says Drug Controller General of India.

On Camera

Bihar mimics 19th-century American South. Citizenship is now weaponised to exclude voters

Disenfranchisement by institutional fiat is profoundly undemocratic. The effect of the ECI's new documentary process in Bihar will tilt the scales in favour of the BJP.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.